-
Benzinga Cannabis Hour Recap: Skye Bioscience CEO Discusses How Cannabinoids May Treat Glaucoma
Thursday, February 11, 2021 - 3:31pm | 527Read More...Cannabinoid receptors distributed within the body are part of the endocannabinoid system that largely affects processes such as mood, memory, pain-sensation, and appetite, to name a few. Two types of receptors — CB1 and CB2 — “play a vital role in managing different body...
-
GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug
Tuesday, November 3, 2020 - 1:00pm | 402Read More...Biopharmaceutical company GW Pharmaceuticals plc (NASDAQ: GWPH) revealed Tuesday that its revenue for the third quarter hit $137.1 million, up by 51% year-over-year. For the first nine months of this fiscal year, total revenue amounted to $378.6 million versus $202.3 million for the...
-
Chan Zuckerberg Initiative Backs Drug Decriminalization In Oregon With $500K
Monday, October 5, 2020 - 1:27pm | 319Read More...Facebook Inc. (NASDAQ: FB) chief executive Mark Zuckerberg and his wife Priscilla Chan backed a campaign poised to decriminalize all drugs in Oregon. According to the Marijuana Moment, the Chan Zuckerberg Initiative Advocacy donated $500,000, which accounts for a third of...
-
These Three Speculative Small Caps Are Loved By Insiders and Institutions
Thursday, August 22, 2013 - 11:55am | 354Read More...Small-cap pharmaceutical companies are as risky as they come. To combat this, investors look at how insiders and institutions are playing these firms with their significant expertise and inside scoop. Anacor Pharmaceuticals (NASDAQ: ANAC) develops small molecule therapeutics, the majority of...
